Prostamax 20 mg

Description

Prostamax (Khavinson Peptide)

Prostamax is a synthetic tetrapeptide bioregulator developed by Professor Vladimir Khavinson. It is designed to support prostate tissue function and is one of the most well-known Khavinson peptides. Prostamax is primarily researched for its potential cytoprotective, anti-inflammatory, and normalizing effects on prostate cells.

Research Properties:

• Prostate Health: Studied for its ability to help regulate prostate cell metabolism and function.
• Anti-Inflammatory: Researched for potential reduction of inflammation in prostate tissue.
• Cellular Normalization: Investigated for its role in supporting healthy prostate cell activity and protein synthesis.
• Age-Related Support: Explored for its potential benefits in age-related prostate changes, including benign prostatic hyperplasia (BPH) models.
• Urinary Function: Studied for possible improvements in urinary flow and comfort in research models.

Key Areas of Research Interest:

• Benign Prostatic Hyperplasia (BPH)
• Chronic prostatitis
• Age-related prostate changes
• Male reproductive health
• Peptide bioregulation

Administration in Research:

• Subcutaneous injection
• Oral administration (capsules) also commonly studied

For Research Use Only. Not for human consumption. Prostamax is intended strictly for laboratory research and in-vitro experimentation.